Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/41520
Title: | Diabetes and CVD risk in women. Optimising outcomes. | Authors: | Crinall B.;Zoungas S. | Institution: | (Crinall) Monash Diabetes, Monash Health, Melbourne, VIC, Australia (Zoungas) Department of Diabetes, Vascular Health and Ageing, Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia (Zoungas) George Institute for Global Health, Sydney, NSW, Australia | Issue Date: | 2-Feb-2017 | Copyright year: | 2015 | Publisher: | Medicine Today Pty Ltd (E-mail: judypasslow@medicinetoday.com.au) | Place of publication: | Australia | Publication information: | Medicine Today. 16 (5) (pp 46-53), 2015. Date of Publication: May 2015. | Journal: | Medicine Today | Abstract: | Women with type 2 diabetes are at high risk of cardiovascular disease. Early identification and modification of diabetes and cardiovascular risk factors, and adherence to clinical management guidelines are essential for optimising outcomes.Copyright © MedicineToday 2015. | Link to associated publication: | Click here for full text options | ISSN: | 1443-430X | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/41520 | Type: | Review | Subjects: | patient care practice guideline review angiotensin receptor antagonist/dt [Drug Therapy] antilipemic agent calcium channel blocking agent/dt [Drug Therapy] dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy] dipeptidyl peptidase IV inhibitor/cb [Drug Combination] dipeptidyl peptidase IV inhibitor/dt [Drug Therapy] ezetimibe/dt [Drug Therapy] glucagon like peptide 1 receptor agonist/dt [Drug Therapy] hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy] insulin/dt [Drug Therapy] metformin/cb [Drug Combination] metformin/dt [Drug Therapy] nicotinic acid/dt [Drug Therapy] sodium glucose cotransporter 2 inhibitor/cb [Drug Combination] sodium glucose cotransporter 2 inhibitor/dt [Drug Therapy] sulfonylurea/cb [Drug Combination] sulfonylurea/dt [Drug Therapy] thiazide diuretic agent/dt [Drug Therapy] bile acid sequestrant/dt [Drug Therapy] add on therapy cardiovascular disease/co [Complication] *cardiovascular risk clinical outcome early diagnosis female high risk patient human hyperlipidemia/dt [Drug Therapy] hypertension/dt [Drug Therapy] *non insulin dependent diabetes mellitus/di [Diagnosis] *non insulin dependent diabetes mellitus/dt [Drug Therapy] *non insulin dependent diabetes mellitus/pc [Prevention] *non insulin dependent diabetes mellitus/th [Therapy] non insulin dependent diabetes mellitus/dt [Drug Therapy] patient care practice guideline Review female early diagnosis clinical outcome *non insulin dependent diabetes mellitus / *diagnosis / *drug therapy / *prevention / *therapy *cardiovascular risk cardiovascular disease / complication hypertension / drug therapy non insulin dependent diabetes mellitus / drug therapy add on therapy hyperlipidemia / drug therapy human high risk patient |
Type of Clinical Study or Trial: | Review article (e.g. literature review, narrative review) |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.